Literature DB >> 7114834

Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates.

G V Doern, D R Scott, A L Rashad.   

Abstract

The results of a rapid, direct blood culture disk susceptibility test indicated that antimicrobial chemotherapy should be changed in 48 of 173 patients with bacteremia. In 32 patients (66.6%), the indicated change was made approximately 24 h sooner than if conventional, nonrapid susceptibility tests had been used to guide therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114834      PMCID: PMC182067          DOI: 10.1128/AAC.21.6.1023

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Standardization of direct susceptibility test for blood cultures.

Authors:  D Fay; J E Oldfather
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

2.  Comparison of direct and standardized antimicrobial susceptibility testing of positive blood cultures.

Authors:  J E Johnson; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

3.  Direct method to determine the antibiotic susceptibility of rapidly growing blood pathogens.

Authors:  D L Wegner; C R Mathis; T R Neblett
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  Evaluation of a direct blood culture disk diffusion antimicrobial susceptibility test.

Authors:  G V Doern; D R Scott; A L Rashad; K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

  4 in total
  14 in total

1.  Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method.

Authors:  T C Chang; A H Huang
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

2.  Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures.

Authors:  Daniel J Diekema; Kathleen Lee; Patti Raney; Loreen A Herwaldt; Gary V Doern; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Strategies for controlling antibiotic use in a tertiary-care paediatric hospital.

Authors:  S A Diamond; B J Hales
Journal:  Paediatr Child Health       Date:  1997-05       Impact factor: 2.253

4.  Direct antimicrobial susceptibility testing of gram-negative bacilli in blood cultures by an electrochemical method.

Authors:  A H Huang; J J Wu; Y M Weng; H C Ding; T C Chang
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Antibiotic susceptibility testing in less than 30 min using direct single-cell imaging.

Authors:  Özden Baltekin; Alexis Boucharin; Eva Tano; Dan I Andersson; Johan Elf
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-08       Impact factor: 11.205

6.  Improving timelines in reporting results from positive blood cultures: simulation of impact of rapid identification on therapy on a real-life cohort.

Authors:  Lien Cattoir; Liselotte Coorevits; Isabel Leroux-Roels; Geert Claeys; Bruno Verhasselt; Jerina Boelens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-05       Impact factor: 3.267

7.  The Confounding Role of Antimicrobial Stewardship Programs in Understanding the Impact of Technology on Patient Care.

Authors:  Christopher D Doern
Journal:  J Clin Microbiol       Date:  2016-08-17       Impact factor: 5.948

8.  Selection criteria for an antimicrobial susceptibility testing system.

Authors:  J H Jorgensen
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

9.  Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates.

Authors:  G M Trenholme; R L Kaplan; P H Karakusis; T Stine; J Fuhrer; W Landau; S Levin
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

10.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.